Drug Pipeline

INO-9012 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
0
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04251117 GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With… HCC Active, Not Recruiting
NCT03491683 INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab… Glioblastoma Active, Not Recruiting
Phase 1
NCT04367675 INO 5401 Vaccination in BRCA1/2 Mutation Carriers BRCA1/2 Mutation Active, Not Recruiting
NCT02772003 DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Chronic Hepatitis Active, Not Recruiting
NCT04015700 Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated… Glioblastoma Active, Not Recruiting
Sponsors Running INO-9012 Trials
Disease Areas
Get alerts when INO-9012 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free